Skip to main content
VI

ValVention, Inc.

ValVention, Inc. develops the FoldaValve™ transcatheter aortic valve replacement system, utilizing a patented sheathed inverse folding mechanism to enhance valve durability and structural integrity. The company targets the growing prevalence of valvular heart disease and aims to provide a less invasive alternative to surgical aortic valve replacement for patients with aortic valve stenosis.

Founded 20183300+ followers
Updated 4 months ago

Funding

$340K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Aortic valve stenosis, a common heart condition especially in elderly patients, often requires valve replacement. Traditional surgical aortic valve replacement (SAVR) is highly invasive, while existing transcatheter aortic valve replacement (TAVR) systems may have limitations in valve durability and structural integrity. The number of patients with severe aortic stenosis is expected to rise to 3.5M by 2050, creating a growing need for less invasive and more durable solutions.

Solution

ValVention's FoldaValve™ system offers a less invasive alternative to surgical aortic valve replacement for patients with aortic valve stenosis. The TAVR system utilizes a patented sheathed inverse folding mechanism designed to enhance valve durability and structural integrity compared to standard crimping methods. The FoldaValve™ system is designed with full repositioning and retrieval capacity, allowing for precise placement and adjustments during the procedure. By addressing unmet clinical needs in valvular heart disease, ValVention aims to reduce the burden of heart failure diseases.

Target Audience

The primary target audience includes elderly patients with aortic valve stenosis who are seeking a less invasive alternative to surgical aortic valve replacement.

Features

  • Patented sheathed inverse folding mechanism for enhanced valve durability
  • Transcatheter delivery for a minimally invasive approach
  • Fully repositionable and retrievable design for precise placement
This profile is AI-generated and may contain inaccuracies.